ABRA Antikörper (AA 13-381) (FITC)
Kurzübersicht für ABRA Antikörper (AA 13-381) (FITC) (ABIN7965643)
Target
Alle ABRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 13-381
-
Verwendungszweck
- Anti-ABRA Antibody FITC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human ABRA recombinant protein (Position: A13-K381).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Andere Bezeichnung
- ABRA
-
Hintergrund
-
Background: Predicted to enable actin binding activity. Predicted to be involved in positive regulation of DNA-binding transcription factor activity, positive regulation of Rho protein signal transduction, and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of transcription, DNA-templated and protein import into nucleus. Located in plasma membrane.
Gene Full Name: actin binding Rho activating protein
-
Gen-ID
- 137735
-
UniProt
- Q8N0Z2
-
Pathways
- Protein targeting to Nucleus
Target
-